Please use this identifier to cite or link to this item: https://doi.org/10.1016/j.clinbiochem.2004.08.006
Title: Platelet-endothelial cell adhesion molecule-1 gene polymorphism and its soluble level are associated with severe coronary artery stenosis in Chinese Singaporean
Authors: Wei, H.
Fang, L.
Chowdhury, S.H.
Gong, N.
Song, J.
Wu, S.
Lim, Y.L.
Chatterjee, S. 
Xiong, Z.
Mak, K.H.
Koay, E. 
Sethi, S. 
Keywords: Atherosclerosis
Coronary artery disease
Gene polymorphism
PECAM-1
Issue Date: 2004
Citation: Wei, H., Fang, L., Chowdhury, S.H., Gong, N., Song, J., Wu, S., Lim, Y.L., Chatterjee, S., Xiong, Z., Mak, K.H., Koay, E., Sethi, S. (2004). Platelet-endothelial cell adhesion molecule-1 gene polymorphism and its soluble level are associated with severe coronary artery stenosis in Chinese Singaporean. Clinical Biochemistry 37 (12) : 1091-1097. ScholarBank@NUS Repository. https://doi.org/10.1016/j.clinbiochem.2004.08.006
Abstract: Platelet-endothelial cell adhesion molecule-1 (PECAM-1) mediates the transendothelial migration of circulating leukocytes, a characteristic change in vascular inflammation leading to atherosclerotic plaque development. We hypothesized that genetic variation and soluble level of PECAM-1 could be associated with coronary artery disease (CAD). We analyzed two single nucleotide polymorphisms (SNPs) of PECAM-1 gene C+373G (Leu125Val) at exon 3, which encodes the first extracellular (Ig)-like domain that mediates the homophilic binding of PECAM-1, and G+1688A (Ser563Asn) at exon 8 in 144 angiographically documented (≥70% stenosis) patients with CAD and 150 age- and sex-matched controls in the Chinese population in Singapore, using a polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) strategy. Level of plasma soluble PECAM-1 (sPECAM-1) was measured by ELISA. The Leu125Val polymorphism was associated with CAD (P < 0.01). Also, the level of sPECAM-1 is was found to be elevated in CAD patients (P = 0.005). Moreover, subjects with the homozygous GG genotype of the Leu125Val polymorphism had higher sPECAM-1 levels (P = 0.005). The level of sPECAM-1 was further correlated to soluble platelet selectin (sP-selectin, also measured by ELISA), platelet count, and total white blood cell count (WBC), suggesting that platelets are a major source of sPECAM-1 and platelet activation and inflammation may contribute to PECAM-1 elevations in CAD patients. The Leu125Val polymorphism of PECAM-1 and the level of sPECAM-1 are associated with CAD in Chinese in Singapore. The level of sPECAM-1 is also associated with platelet activation and inflammation and correlated to the Leu125Val polymorphism. Our data suggest that PECAM-1 plays an important role in the development of atherosclerosis. © 2004 The Canadian Society of Clinical Chemists. All rights reserved.
Source Title: Clinical Biochemistry
URI: http://scholarbank.nus.edu.sg/handle/10635/30464
ISSN: 00099120
DOI: 10.1016/j.clinbiochem.2004.08.006
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

35
checked on Nov 14, 2018

WEB OF SCIENCETM
Citations

30
checked on Nov 14, 2018

Page view(s)

196
checked on Oct 28, 2018

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.